Quantitative mRNA analysis of serotonin 5-HT4 receptor isoforms, calcium handling proteins and ion channels in human atrial fibrillation

Biochemical and Biophysical Research Communications

Volumn 357, Issue 1, 2007, Pages 218-224

  Lezoualc'h, Frank ^a,b   Steplewski, Klaudia ^c   Sartiani, Laura ^d   Mugelli, Alessandro ^d   Fischmeister, Rodolphe ^a,b   Bril, Antoine ^c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Arrhythmia; Calcium handling proteins; Channel currents; G protein coupled receptor; Serotonin

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CONNEXIN 43; CYCLOPHILIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; ION CHANNEL; MESSENGER RNA; RNA; SEROTONIN 4 RECEPTOR; SODIUM CALCIUM EXCHANGE PROTEIN; VOLTAGE GATED POTASSIUM CHANNEL;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART CONTRACTION; HEART RHYTHM; HEART RIGHT ATRIUM PRESSURE; HOUSEKEEPING GENE; HUMAN; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SINUS RHYTHM; SODIUM CALCIUM EXCHANGE;

ATRIAL FIBRILLATION; CALCIUM; CALCIUM CHANNELS; HEART ATRIA; HUMANS; PROTEIN ISOFORMS; RECEPTORS, SEROTONIN, 5-HT4; RNA, MESSENGER;

EID: 34147192514     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.124     Document Type: Article

References (43)

1. Chatap G., Giraud K., and Vincent J.P. Atrial fibrillation in the elderly-Facts and management. Drugs & Aging 19 (2002) 819-846
2. Allessie M.A., Boyden P.A., Camm A.J., Kleber A.G., Lab M.J., Legato M.J., Rosen M.R., Schwartz P.J., Spooner P.M., Van Wagoner D.R., and Waldo A.L. Pathophysiology and prevention of atrial fibrillation. Circulation 103 (2001) 769-777
3. Heist E.K., and Ruskin J.N. Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment. Prog. Cardiovasc. Dis. 48 (2006) 256-269
4. Almassi G.H., Schowalter T., Nicolosi A.C., Aggarwal A., Moritz T.E., Henderson W.G., Tarazi R., Shroyer A.L., Sethi G.K., Grover F.L., and Hammermeister K.E. Atrial fibrillation after cardiac surgery: a major morbid event?. Ann. Surg. 226 (1997) 501-511
5. Bril A. Recent advances in arrhythmia therapy: treatment and prevention of atrial fibrillation. Curr. Opin. Pharmacol 2 (2002) 154-159
6. Khairy P., and Nattel S. New insights into the mechanisms and management of atrial fibrillation. CMAJ 167 (2002) 1012-1020
7. Schoonderwoerd B.A., Van Gelder I.C., Van Veldhuisen D.J., Van den Berg M.P., and Crijns H.J. Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation. Prog. Cardiovasc. Dis. 48 (2005) 153-168
8. 4 receptors mediate arrhythmias?. Trends Pharmacol. Sci. 15 (1994) 451-455
9. f and human atrial arrhythmia. Cardiovasc. Res. 40 (1998) 436-437
10. 4 receptor ligands: applications and new prospects. J. Med. Chem. 46 (2003) 319-344
11. 4 receptor isoforms produced by alternative splicing in the carboxyl terminus. J. Neurochem. 70 (1998) 2252-2261
12. 4 receptors. Mol. Pharmacol. 41 (1992) 346-351
13. 4 receptor isoforms in adult cardiomyocytes. J. Mol. Cell Cardiol. 39 (2005) 335-344
14. f in human isolated atrial myocytes. Cardiovasc. Res. 40 (1998) 516-522
15. 4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle. Naunyn. Schmiedebergs. Arch. Pharmacol. 363 (2001) 146-160
16. 4 mRNA in heart failure. Naunyn. Schmiedebergs. Arch. Pharmacol. 370 (2004) 157-166
17. Schoemaker R.G., Du X.Y., Bax W.A., Bos E., and Saxena P.R. 5-Hydroxytryptamine stimulates human isolated atrium but not ventricle. Eur. J. Pharmacol. 230 (1993) 103-105
18. 4 receptor-mediated inotropic response to serotonin in heart failure. Cardiovasc. Res. 65 (2005) 869-878
19. Qvigstad E., Sjaastad I., Brattelid T., Nunn C., Swift F., Birkeland J.A., Krobert K.A., Andersen G.O., Sejersted O.M., Osnes J.B., Levy F.O., and Skomedal T. Dual serotonergic regulation of ventricular contractile force through 5-HT2A and 5-HT4 receptors induced in the acute failing heart. Circ. Res. 97 (2005) 268-276
20. 4 receptor antagonist RS-100302 in experimental atrial flutter and fibrillation. Circulation 100 (1999) 2010-2017
21. 2-adrenoceptors in human atrium: functional implications. Naunyn-Schmied. Arch. Pharmacol. 353 (1996) 592-595
22. 4 receptor in the central nervous system by TaqMan real time RT-PCR. Mol. Brain Res. 90 (2001) 125-134
23. 2+-channel, beta-adrenoreceptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation. Basic. Res. Cardiol. 96 (2001) 82-90
24. Bers D.M. Cardiac excitation-contraction coupling. Nature 415 (2002) 198-205
25. Goette A., Arndt M., Rocken C., Spiess A., Staack T., Geller J.C., Huth C., Ansorge S., Klein H.U., and Lendeckel U. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 101 (2000) 2678-2681
26. Brundel B.J.J.M., Henning R.H., Kampinga H.H., Van Gelder I.C., and Crijns H.J.G.M. Molecular mechanisms of remodeling in human atrial fibrillation. Cardiovasc. Res. 54 (2002) 315-324
27. Brundel B.J., Van Gelder I.C., Henning R.H., Tieleman R.G., Tuinenburg A.E., Wietses M., Grandjean J.G., Van Gilst W.H., and Crijns H.J. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 103 (2001) 684-690
28. 2+-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban - An insight into the mechanism of atrial electrical remodeling. J. Am. Coll. Cardiol 33 (1999) 1231-1237
29. Yamada J., Ohkusa T., Nao T., Yano M., Kobayashi S., Hamano K., Esato K., and Matsuzaki M. Up-regulation of inositol 1,4,5-trisphosphate receptor expression in atrial tissue in patients with chronic atrial fibrillation. J. Am. Coll. Cardiol. 37 (2001) 1111-1119
30. Schotten U., Greiser M., Benke D., Buerkel K., Ehrenteidt B., Stellbrink C., VazquezJimenez J.F., Schoendube F., Hanrath P., and Allessie M. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. Cardiovasc. Res. 53 (2002) 192-201
31. Bers D.M., Pogwizd S.M., and Schlotthauer K. Upregulated Na/Ca exchange is involved in both contractile dysfunction and arrhythmogenesis in heart failure. Basic Res. Cardiol. 97 Suppl 1 (2002) I36-I42
32. Bosch R.F., Zeng X.R., Grammer J.B., Popovic K., Mewis C., and Kuhlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc. Res. 44 (1999) 121-131
33. Nerbonne J.M., and Kass R.S. Molecular physiology of cardiac repolarization. Physiol. Rev. 85 (2005) 1205-1253
34. Yue L.X., Melnyk P., Gaspo R., Wang Z.G., and Nattel S. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ. Res. 84 (1999) 776-784
35. Brundel B.J.J.M., Van Gelder I.C., Henning R.H., Tuinenburg A.E., Deelman L.E., Tieleman R.G., Crandjean J.G., Van Gilst W.H., and Crijns H.J.G.M. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc. Res. 42 (1999) 443-454
36. Lai L.P., Su M.J., Lin J.L., Lin F.Y., Tsai C.H., Chen Y.S., Tseng Y.Z., Lien W.P., and Huang S.K. Changes in the mRNA levels of delayed rectifier potassium channels in human atrial fibrillation. Cardiology 92 (1999) 248-255
37. 2 are not downregulated in atrial myocardiurn of patients with chronic atrial fibrillation. J. Mol. Cell. Cardiol. 35 (2003) 437-443
38. + current in a chronic dog model of atrial fibrillation. Circ. Res. 81 (1997) 1045-1052
39. Yagi T., Pu J.L., Chandra P., Hara M., Danilo P., Rosen M.R., and Boyden P.A. Density and function of inward currents in right atrial cells from chronically fibrillating canine atria. Cardiovasc. Res. 54 (2002) 405-415
40. van der Velden H.M.W., and Jongsma H.J. Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets. Cardiovasc. Res. 54 (2002) 270-279
41. Elvan A., Wylie K., and Zipes D.P. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling. Circulation 94 (1996) 2953-2960
42. van der Velden H.M., van Kempen M.J., Wijffels M.C., van Zijverden M., Groenewegen W.A., Allessie M.A., and Jongsma H.J. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J. Cardiovasc. Electrophysiol. 9 (1998) 596-607
43. 40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation 103 (2001) 842-849